Global Sexually Transmitted Diseases Testing Market

Global sexually transmitted diseases testing market by component (consumables, instruments, software), by location of testing (laboratory testing, point of care (PoC) testing), by technology (immunoassays, polymerase chain reaction (PCR), others), by application (chlamydia, genital herpes, gonorrhea, hepatitis B, HIV and AIDS, human papillomavirus (HPV), syphilis, others), by region (North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America), outlook & forecast, 2023-2029

Report Code: GH04069R Industry: Region:
Description

Sexually transmitted diseases (STDs), also known as sexually transmitted infections (STIs), are infections or conditions that can be acquired from any kind of sexual activity involving a person’s mouth, anus, vagina, or penis. There are several types of STDs. The most common symptoms are burning, itching, or discharge from the genital area. Sexually transmitted infections are really common and many people don’t have any symptoms when they are infected. If left untreated, STDs can lead to serious health problems. The global sexually transmitted diseases testing market is anticipated to increase by USD 4.7 billion till 2029 at an average annual growth of 7.3 percent as per the latest market estimates.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global sexually transmitted diseases testing market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the component, location of testing, technology, application, and region. The global market for sexually transmitted diseases testing can be segmented by component: consumables, instruments, software. The consumables segment was the largest contributor to the global sexually transmitted diseases testing market in 2022. Sexually transmitted diseases testing market is further segmented by location of testing: laboratory testing, point of care (PoC) testing. According to the research, the laboratory testing segment had the largest share in the global sexually transmitted diseases testing market. Based on technology, the sexually transmitted diseases testing market is segmented into: immunoassays, polymerase chain reaction (PCR), others. The immunoassays segment held the largest revenue share in 2022. On the basis of application, the sexually transmitted diseases testing market also can be divided into: chlamydia, genital herpes, gonorrhea, hepatitis B, HIV and AIDS, human papillomavirus (HPV), syphilis, others. Sexually transmitted diseases testing market by region is categorized into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America.

Market Segmentation
By component: consumables, instruments, software
By location of testing: laboratory testing, point of care (PoC) testing
By technology: immunoassays, polymerase chain reaction (PCR), others
By application: chlamydia, genital herpes, gonorrhea, hepatitis B, HIV and AIDS, human papillomavirus (HPV), syphilis, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report also provides analysis of the key companies of the industry and their detailed company profiles including Abbott Laboratories, AbbVie Inc., Agilent Technologies, Inc., Becton, Dickinson and Company, bioMerieux SA, Bio-rad Laboratories, Inc., Danaher Corporation, DiaSorin S.p.A., Esco Micro Pte. Ltd., F. Hoffmann-La Roche AG, Gen-Probe Incorporated (Hologic, Inc.), MedMira Holding AG, Meridian Bioscience Inc., OraSure Technologies, Inc., Qiagen N.V., QuantuMDx Group Ltd., QuidelOrtho Corporation, Seegene, Inc., Sekisui Medical Co., Ltd., Siemens Healthineers AG, Thermo Fisher Scientific, Inc., Trinity Biotech Plc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Scope of the Report
• To analyze and forecast the market size of the global sexually transmitted diseases testing market.
• To classify and forecast the global sexually transmitted diseases testing market based on component, location of testing, technology, application, region.
• To identify drivers and challenges for the global sexually transmitted diseases testing market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global sexually transmitted diseases testing market.
• To identify and analyze the profile of leading players operating in the global sexually transmitted diseases testing market.

Why Choose This Report
• Gain a reliable outlook of the global sexually transmitted diseases testing market forecasts from 2023 to 2029 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Global Sexually Transmitted Diseases Testing Market

Interested in this report? Get your FREE sample now!

$3,050.00

Code: GH04069R Industry: Region:

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
Global Sexually Transmitted Diseases Testing Market

Please fill out our form and we will get back to you.